Proteins Significantly Decreased only in Metastatic UM Tumors. by John W. Crabb (158933)

“…<p>Average ratio (UM/control), standard error of mean (SEM), and p values (t-test) are shown for proteins significantly decreased only in metastatic tumors in LC MS/MS iTRAQ analyses of 5 metastatic and 5 non-metastatic primary UM tumors.…”

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

Mean ± SD values for the parameters found with fittings of Eq. 8, S1 Appendix) to the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and maximum hor... by Kai Roecker (847195)

Subjects:

Division of carpal tunnel into quartiles to calculate volume distribution. by Drew A. Anderson (14197446)

Subjects:

Autophagy inhibition decrease LAMP2 levels and survival of neuroendocrine differentiated LNCaP cells. by Cecilia Morell (729630)

TRIM5 restriction of HIV-1 has decreased during evolution leading to humans. by Michael Emerman (12304)

“…<p>The shading of the rectangle represents the degree that TRIM5 will limit infection of HIV-1 (darker color means TRIM5 decreases HIV-1 infection more) and the X-axis indicates time in millions of years from the present. …”

MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

“…</b> Histogram depicting the distribution of increased and decreased miRNAs between control and CRS mice. <b>I.…”

Overexpression of Lethe in RAW macrophage cells decreases ROS production. by Carlos Zgheib (311460)

Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease by Gonçalo da Costa (198731)

A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…<p>(A) Schematic showing the location of the mutation in the <i>Mrps34</i> gene, mRNA and protein. The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Mean ± SD values for the parameters found when Eq. 8 (S1 Appendix) was used to model the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and the weig... by Kai Roecker (847195)

Subjects:

Non-hydrolysable ATP analogues prevent decrease of I_Ca,L by metabolic inhibition. by Giedrius Kanaporis (4405525)

Cephalometric measurement points. by Lijuan Liu (136685)

Subjects:

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in primary NPCs. by Ryohei Minamide (505053)

Decreased expression of the γ-glutamylcysteine ligase and increased hepatic oxidant generation and protein oxidative damage at Day+4 in Allo BMT. by Jung H. Suh (523844)